The biotechnology company Aker BioMarine has signed an agreement to be the exclusive supplier of the company’s Superba™ Krill Oil dietary supplement to the market leader Schiff Nutrition International. The agreement is a major breakthrough for Aker BioMarine in the US market.
“Schiff Nutrition is the ideal partner, and the agreement represents a major recognition of the quality of Superba™. Schiff’s expertise and achievements in brand-building and sales of dietary supplement products are impressive,” says Hallvard Muri, Aker BioMarine’s President and CEO.
“Schiff Nutrition has chosen Aker BioMarine as its exclusive krill oil supplier. This means that Superba™ will be found in thousands of stores in the rapidly growing US market for omega-3 products,” Mr. Muri says.
Superba™ Krill Oil will be the branded ingredient in MegaRed®, a Schiff Nutrition product. For more than 70 years, Schiff Nutrition has been a leader in the US dietary supplements market. Schiff MegaRed® is the most successful krill-oil-based omega-3 product and one of the fastest growing omega-3 products in the US market. Mega Red is available in most mass market retailers throughout the United States.
“We are impressed by Aker BioMarine's quality and technical capabilities, as evidenced by its EcoHarvesting™ technique of Antarctic krill,” says Bruce Wood, President and CEO of Schiff Nutrition International. “Aker BioMarine controls every step in the value chain and provides complete traceability of the raw material, supported by detailed documentation of every processing stage. This gives us confidence in Aker BioMarine’s quality, supply reliability, and sustainability, all critical factors for selection as a Schiff Nutrition supplier. We look forward to a productive, long-term cooperative relationship with Aker BioMarine.”
About Aker BioMarine
Aker BioMarine ASA uses proprietary EcoHarvesting™ technology to sustainably harvest Antarctic krill (Euphausia superba). Aker BioMarine develops, manufactures, and markets Superba™ Krill − high-quality phospholipid-bound omega-3 krill-derived nutraceutical products that have demonstrated higher uptake and utilization in pre-clinical and clinical studies. The company also offers Qrill™ − a krill-derived functional feed that has been demonstrated to significantly promote health and growth in various farmed fish and shrimp species. Aker BioMarine ASA is listed on the Oslo Stock Exchange (OSE:AKBM) and is owned 82.9% by Aker ASA. Founded in 1841, Aker controls companies with an aggregate of 26,500 employees and more than USD 10 billion of revenues in 2008.